arrow
L

Luca Landoni

irccs policlinico gemelli
H指数:56
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multi-omic profiles of neuroendocrine neoplasms of the pancreas: an integrated landscape

胰腺神经内分泌肿瘤的多组学图谱:综合分析

2026-05-290
OA
Impact of endoscopic ultrasound-guided fine-needle biopsy on management of suspected small (11-20 mm) and very small (≤10 mm) low-risk nonfunctioning pancreatic neuroendocrine tumors

内镜超声引导下细针活检对疑似小(11-20 mm)和极小(≤10 mm)低风险无功能性胰腺神经内分泌肿瘤管理的影响

Endoscopy
IF12.8
2026-05-010
PRE
Pancreatic stump perfusion assessment using indocyanine green fluorescence and its impact on postoperative pancreatic fistula: A systematic review and meta-analysis

使用吲哚菁绿荧光评估胰腺残端灌注及其对术后胰腺瘘的影响:一项系统评价和Meta分析

Surgery
IF2.7
2025-12-080
PRE
Minimally invasive Distal Pancreatectomy eRgonOMic analysis - the DP-ROM trial: An explorative, prospective, observational, cohort study trial

微创远端胰腺切除术人机工程学分析 - DP-ROM试验:一项探索性、前瞻性、观察性队列研究试验

2025-10-010
OAAI
Intraoperative hepatic ultrasonography in patients with gastrointestinal and pancreatic neuroendocrine neoplasms without preoperative evidence of liver metastases

术中肝超声检查在无术前肝脏转移证据的胃肠胰神经内分泌新生物患者中的应用

2025-08-180
OAAI
Somatostatin analogs for resectable pancreatic neuroendocrine tumors in high-risk surgical patients: Data from a single-center cohort

生长抑素类似物在高危手术患者可切除胰腺神经内分泌肿瘤中的应用:单中心队列研究数据

2025-04-040
PRE
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres)

产生胰高血糖素的胰腺神经内分泌肿瘤 (胰高血糖素瘤) 富含具有ARX和PDX1共表达,DAXX/ATRX突变和ALT (端粒的替代延长) 的侵袭性肿瘤

2024-09-270
OAAI
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
2024-07-011
OA
Thirty-day prevalence and clinical impact of fluid collections at the resection margin after distal pancreatectomy: Follow-up of a multicentric randomized controlled trial
SURGERY
IF2.7
2024-07-011
PRE
The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine Tumors
2024-03-220
PRE
The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine Tumors

教科书结果对无功能胰腺神经内分泌肿瘤胰十二指肠切除术的基准价值

2024-03-104
PRE
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database
2024-01-043
OAAI
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial

可切除胰腺导管腺癌患者的围手术期NALIRIFOX: 开放标签,多中心,II期nITRO试验

2024-01-016
OA
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma
2023-09-0115
OAAI